Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
68results about How to "Treatment reached" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Traditional Chinese medicine combination for treating bone injury and fracture and preparation method of the same
InactiveCN102078482ARelieve excruciating painPromote generationAmphibian material medical ingredientsAnthropod material medical ingredientsSalvia miltiorrhizaOral medicine
The invention discloses a traditional Chinese medicine combination for treating bone injury and fracture, which is characterized by comprising oral medicines and external-use medicines, wherein the oral medicines comprise the following active pharmaceutical ingredients: astragalus, angelica sinensis, barrenwort, herba cistanche, pseudo-ginseng, achyranthes root, safflower, cortex eucommiae, salvia miltiorrhiza, rhizomadrynariae, yam, fructus psoralea, sambucus williamsii hance, woodwardia japonica, prepared radix rehmanniae, lumbricus and white peony root; and the external-use medicines comprise various active pharmaceutical ingredients: myrrh, fructus evodiae, teasel, pseudo-ginseng, safflower, rhizoma ligustici wallichii, nux vomica, toad skin, centipede, notopterygium and herba lycopodti. The traditional Chinese medicine combination activates osteoblasts of endosteum and periosteum at the bone injury and fracture site to rapidly calcify, thereby having special efficacy to promote the generation a new bone. The traditional Chinese medicine combination is suitable for treating various bone injuries and fractures, has high cure rate, relieve severe pains of the bone injury and fracture of mass patients without using strong analgesics, can promote bone callus to rapidly form and has the effects of relieving flatulence and pains, eliminating blood stasis and promoting tissue regeneration and growth of the bone callus.
Owner:刘兰梅
Application of antiplatelet thrombolysin in preparation of medicine for treating thrombotic thrombocytopenic purpura (TTP)
PendingCN105833255ARecovery levelLower levelPeptide/protein ingredientsBlood disorderAnti plateletThrombasthenia
The invention relates to the field of medicines and especially relates to an application of antiplatelet thrombolysin in preparation of a medicine for treating thrombotic thrombocytopenic purpura (TTP). The antiplatelet thrombolysin limits adhesion and aggregation of platelets, recovers levels of the platelets, erythrocytes and hemoglobin, reduces level of lactic dehydrogenase and effectively inhibits thrombocytopenia and cleaved-cell hemolyticanemia, thereby treating the TTP. The antiplatelet thrombolysin has great clinical application prospect.
Owner:ZHAOKE PHARMA HEFEI
Application of chlorogenic acid in preparation of medicine for treating melanoma and medicine for treating melanoma
InactiveCN104688720AImprove treatmentTreatment reachedHeavy metal active ingredientsOrganic chemistryChlorogenic acidMonocyte
The invention discloses an application of a chlorogenic acid in preparation of a medicine for treating melanoma and the medicine for treating melanoma. An experiment proves that the chlorogenic acid is capable of promoting monocyte to polarize towards M1 macrophages, inhibiting the monocyte to polarize towards M2 macrophages, inhibiting the M1 macrophages to transform towards the M2 macrophages, inhibiting the M2 macrophages to transform towards the M1 macrophages, so that the target of treating the melanoma is finally reached.
Owner:SICHUAN JIUZHANG BIO TECH CO LTD
Micronize diosmin and hesperidine composition suppository
InactiveCN1823807AAppropriate hardnessAppropriate toughnessOrganic active ingredientsSuppositories deliveryGynecologyDiosmin
A composite suppository for treating pile, phlebitis and phlebeurysma is prepared from micro-granular diosmin and hesperidin, matrix for suppository and additive.
Owner:刘展欣
Diagnosis marker and treatment target of renal clear cell carcinoma
InactiveCN107385083ATreatment reachedCompound screeningApoptosis detectionLymphatic SpreadCancer cell
The invention discloses a diagnosis marker and treatment target of renal clear cell carcinoma and belongs to the technical field of gene new application. The diagnosis marker and treatment target is MRO. The diagnosis marker and treatment target has the advantages that the fact that the expression of the marker MRO in a renal clear cell carcinoma is reduced is discovered for the first time, the proliferation, migration and invasion of cancer cells can be lowered by increasing the expression of the MRO, and the MRO serving as the target can be used for treating the renal clear cell carcinoma and renal carcinoma metastasis.
Owner:QINGDAO MEDINTELL BIOMEDICAL CO LTD
Application of CD200 protein and CD200 fusion protein in preparation of drugs for treating psoriasis
PendingCN110859951ATreatment reachedInhibition of activationPeptide/protein ingredientsPharmaceutical non-active ingredientsInflammatory factorsPharmaceutical drug
The invention discloses an application of CD200 in psoriasis, and belongs to the field of biological medicines. The invention specifically relates to an application of CD200 protein or CD200 fusion protein in treatment of psoriasis. Through the research, when an effective amount of exogenous CD200 protein or CD200 fusion protein is given in vitro, NF-kappa B signal transduction can be inhibited, the activation of inflammatory macrophages is inhibited, the secretion of IL-1beta, IL-6 and TNF-alpha inflammatory factors and the excessive proliferation of keratinocytes can be reduced, so that theprotein can be applied to psoriasis treatment.
Owner:CHINA PHARM UNIV
Method for purifying phage through chromatography
InactiveCN101921734AOvercome poor drug efficacyTreat bacterial diseasesRecovery/purificationMultiple drug resistanceBacterial disease
The invention relates to a method for purifying phage through chromatography, which comprises the following steps of: (1) amplifying the phage; (2) enriching the phage to obtain a phage suspension; and (3) performing column chromatography: performing column chromatography to the enriched phage to obtain the purified phage, wherein a column packing material for column chromatography is sepharose 4B gel or DEAE-52 resin. The purified phage can be applied to clinic treatment and can overcome the defect of poor drug curative effect caused by antibiotic abuse and production of pathogenic drug-resisting stains. Under the current situation that multiple drug-resisting stains widely exist and no effective treatment method is available, the phage can be used for cracking pathogenic bacteria and killing host cells, and thus, the purpose of treating bacterial disease is achieved.
Owner:TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY
Compound dendrobe eye drops for treating xerophthalmia and preparation method thereof
InactiveCN104367832ARich sources of medicineLow costSenses disorderPharmaceutical delivery mechanismTreatment effectOcular surface
The invention belongs to the field of traditional Chinese medicines, relates to a traditional Chinese medicine prescription for treating xerophthalmia and a preparation method thereof, and particularly relates to compound dendrobe eye drops for treating xerophthalmia and a preparation method thereof. The eye drops are prepared from the following raw materials by weight: 80-120g of dendrobe, 80-120g of radix trichosanthis, 80-120g of folium isatidis, 50-100g of vitamin B1 and 10-20ml of honey. The eye drops are prepared by adopting a modern advanced pharmaceutical technology, are reasonable in formula, and are scientific and advanced; the medicinal materials are rich in source and low in cost, and have the effects of improving eyesight, diminishing inflammation, nourishing ocular surface and promoting growth of corneal epithelium; the eye drops can directly reach the acting position by adopting a local administration mode, so that an ophthalmic medicine preparation which is safe, effective and convenient to use is provided to clinical treatment of xerophthalmia, is reliable in treatment effect and has generalizability.
Owner:QINGDAO MUNICIPAL HOSPITAL
Intensive culture method for improving rhinogobio ventralis larva culture survival rate
ActiveCN105994039AEffective controlReduce the probability of small melon bug outbreaksFodderClimate change adaptationIchthyophthiriasisJuvenile fish
The invention provides an intensive culture method for improving rhinogobio ventralis larva culture survival rate. The method comprises the steps of: step 1, pre-larva culture, step 2, post-larva culture, and step 3, juvenile fish culture. In the step 3, juvenile rhinogobio ventralis is cultured in a small water culture pond. An artificial compound feed is used for feeding twice a day. After each feeding, the small water culture pond is cleaned in time, and 60-80wt% of water in the small water culture pond is replaced. With the intensive culture method for improving rhinogobio ventralis larva culture survival rate, a problem that rhinogobio ventralis larvae and juvenile are vulnerable to ichthyophthiriasis can be solved. Ichthyophthiriasis is effectively controlled during the rhinogobio ventralis larva culture stage, and rhinogobio ventralis larva culture survival rate is improved. Therefore, a basis is established for the breaking-through of rhinogobio ventralis larva large-scale culture technology.
Owner:CHINESE STURGEON RES INST CHINA THREE GOR
Traditional Chinese medicine preparation for treating heart diseases and preparation method therefor
ActiveCN103316217ATreatment reachedMildAmphibian material medical ingredientsCardiovascular disorderBiotechnologyBletilla striata
Provided is a traditional Chinese medicine preparation for treating heart diseases and a preparation method therefor. The traditional Chinese medicine preparation is prepared from the following raw materials which are made into active ingredients. The raw materials comprise, by weight, 25-40 parts of giant salamander bone and meat powder, 3-8 parts of giant salamander internal organ powder, 10-25 parts of donkey-hide gelatin, 10-25 parts of bletilla striata, 10-18 parts of radix rehmanniae, 15-25 parts of Chinese angelica, 20-30 parts of white peony root and 15-30 parts of ligusticum chuanxiong hort. The preparation method comprises steps: (1) giant salamanders with bones are steamed, dried and crushed to obtain the giant salamander bone and meat powder; (2) livers, spleens and stomachs of internal organs of the giant salamanders are dried at a low temperature, crushed and ground to powder; (3) the radix rehmanniae, the Chinese angelica, the bletilla striata, the white peony root and the ligusticum chuanxiong hort are added into water, boiled over high heat, decocted over gentle heat for 30-40 min and filtered, the weight ratio of the materials to the water is 1:2-3; (4) the substances obtained from step (1), step (2) and step (3) are added into the donkey-hide gelatin and then decocted over gentle heat for 12-26 min. The traditional Chinese medicine preparation is used to treat heart diseases. The traditional Chinese medicine preparation is mild and advantaged by rapid effect, high effective rate and minimal side effects.
Owner:张家界金鲵生物工程股份有限公司
Drink for treating xerophthalmia and alacrimia
InactiveCN1554389AImprove secretion capacityTreatment reachedSenses disorderUnknown materialsNutrientEye disease
The drink capable of treating xerophthalmia and alacrimia is prepared with frosted mulberry leaf, chrysanthemum, black bean, cassia see and honey, and through decocting the first four kinds of Chinese medicinal materials, filtering to eliminate medicine dregs and compounding while adding honey. The present invention is prepared through combining the medicinal food materials mulberry leaf, chrysanthemum, black bean and cassia see with eye disease treating function to generate synergistic effect and adding honey to season and replenish nutrients and to reinforce the secretion function of tear gland, so that the present invention can reach the aim of treating xerophthalmia and alacrimia.
Owner:吕莎
Application of miR-130a to diagnosis, treatment and prognosis of ovarian cancer
ActiveCN106636368AObvious negative correlationPrevent invasionMicrobiological testing/measurementAntineoplastic agentsAbnormal tissue growthGynecology
The invention discloses application of miR-130a to diagnosis, treatment and prognosis of ovarian cancer. The miR-130a is defined, through in-vivo and in-vitro function test, that an mTOR (mammalian Target of Rapamycin) signal path is over-expressed through inhibiting translation of TSC1mRNA (Tuberous Sclerosis 1 Messenger RNA (Ribonucleic Acid)) by the miR-130a, so that proliferation and invasion of ovarian cancer cells are promoted and autophagy of the cells is inhibited. The data testifies that the miR-130a with a reduced endogenous property can be used for inhibiting malignant biological behaviors including growth, invasion and the like of ovarian cancer tumors. Based on the characteristics, a specific miR-130a inhibitor can be designed, the content of TSC1 in a body is recovered and the mTOR signal path is inhibited, so that the aim of treating the ovarian cancer is realized.
Owner:SHANDONG UNIV
Chinese traditional medicine for treating pulmonary heart disease
A Chinese medicine in the form of decoction or capsule for treating pneumocardial disease is prepared from 13-20 Chinese-medicinal materials including peach kernel, safflower, tangerine peel, cordyceps, etc.
Owner:杨国兴 +2
Application of RS1 gene in preparation of XLRS therapeutic agent and therapeutic agent
PendingCN114848850ATreatment reachedHigh expressionSenses disorderPharmaceutical delivery mechanismDiseasePharmaceutical drug
The invention relates to application of an RS1 gene in preparation of an X-linked retina splitting disease therapeutic agent. The invention further relates to a therapeutic agent for the X-linked retina splitting disease, the therapeutic agent comprises an RS1 gene expression vector, and the RS1 gene expression vector contains an RS1 gene expression cassette. The RS1 gene sequence in the RS1 gene expression cassette is a codon optimized sequence, the promoter for controlling the RS1 gene expression is a CMV promoter, and the RS1 gene expression cassette also comprises a non-coding regulatory sequence. The therapeutic agent capable of effectively treating the X-linked retina splitting disease is obtained by constructing an efficiently expressed RS1 gene expression vector, and after the therapeutic agent is applied to a vitreous cavity in an injection mode, the expression of RS1 protein can be remarkably improved, so that the aim of treating the X-linked retina splitting disease is achieved, and the therapeutic agent has a wide application prospect in treatment of the X-linked retina splitting disease. The compound is hopeful to become a candidate drug for treating X-linked retinopathy.
Owner:武汉中眸生物科技有限责任公司
Traditional Chinese medicine preparation for treating proteinuria of chronic nephritic syndrome
The invention discloses a traditional Chinese medicine preparation for treating proteinuria of a chronic nephritic syndrome. The traditional Chinese medicine preparation comprises Radix Astragali, Herba Rhodiolae Sacrae, Radix Codonopsis, stir-fried Rhizoma Atractylodis Macrocephalae with bran, Semen Nelumbinis, Semen Euryales, Herba Eupatorii, Radix Angelicae Sinensis, Herba Epimedii, processed Desertliving Cistanche with wine, Fructus Rubi, processed Fructus Corni with wine, Semen Cuscutae, Rhizoma Rehmanniae Preparata, Rhizoma Dioscoreae, processed Fructus Ligustri Lucidi with wine, processed Rhizoma Polygonati with wine, Semen Coicis, Herba Polygoni Avicularis, Semen Phaseoli, Herba Plantaginis, Poria peel, fresh Exocarpium Benincasae, Fructus Leonuri, Herba Hedyotis Diffusae, Fructus Forsythiae, Rhizoma Dioscoreae Nipponicae, Rhizoma Cyperi and Ostrea (coarse powder). The traditional Chinese medicine preparation for treating proteinuria of the chronic nephritic syndrome is capable of invigorating the spleen and the kidney, clearing heat, promoting diuresis, detoxifying and promoting blood circulation to remove blood stasis so as to treat chronic nephritis with the symptoms of spleen-kidney qi deficiency and damp-heat.
Owner:山东康美药业有限公司
Traditional Chinese medicine composition for treating hot cold
InactiveCN104258095ASignificant runny noseSignificant nasal congestionAntipyreticAnalgesicsOfficinalisHeadaches
The invention discloses a traditional Chinese medicine composition for treating hot cold. The composition comprises the following raw materials in parts by weight: 10-12 parts of golden cypress, 4-5 parts of semen plantaginis, 2-4 parts of leaf of pubescent holly, 5-7 parts of radix scutellariae, 3-5 parts of rhizoma anemarrhenae, 2-4 parts of herba houttuyniae, 5-6 parts of folium perillae, 2-4 parts of semen armeniacae amarum, 1-2 parts of immature bitter orange, 4-5 parts of cortex magnoliae officinalis, 6-7 parts of stir-fried lablab, 3-5 parts of fructus arctii, 2-5 parts of fructus rosae laevigatae, 1-3 parts of rhododendron simsii planch, 4-5 parts of notopterygium root, 5-7 parts of plantain herb, 2-4 parts of bark of tulip tree, 1-3 parts of Nagens Groundsel and 2-4 parts of herb of creeping rattlesnake plantain. The various components are combined to achieve the efficacies of clearing heat, detoxifying, dispelling wind and heat, regulating qi and relieving melancholy; the composition has an obvious effect in treating symptoms of running nose, nasal obstruction, headache and mild fever caused by hot cold and the purpose of curing hot cold is achieved.
Owner:HEFEI FENG RUI LONG BIO TECH
Applications of human SAMD9L gene and protein product encoded by human SAMD9L gene
InactiveCN103571927AAccurate diagnosisRapid diagnosisPeptide/protein ingredientsMicrobiological testing/measurementOpen reading frameLymphatic Spread
The present invention discloses applications of human SAMD9L gene and a protein product encoded by the human SAMD9L gene, wherein the SAMD9L gene sequence, especially the open reading frame sequence of the protein encoded by the human SAMD9L gene, generates missense mutation, nonsense mutation, frameshift mutation and other gene structure variations with different forms in tumors so as to be adopted as the specific marker gene for liver cancer diagnosis, such that liver cancer diagnosis is accurate and rapid. According to the present invention, the human SAMD9L protein can be applied on tumor patients so as to treat or alleviate related diseases caused by SAMD9L protein deletion, nonfunction or abnormality; and the human SAMD9L gene can be over-expressed in cancer cells through the transgenic technology, or the SAMD9L protein can be supplied through the in vitro supply manner to control cancer cell proliferation and metastasis so as to achieve the tumor treatment purpose.
Owner:CHINESE NAT HUMAN GENOME CENT AT SHANGHAI
Formula of western medicine for treating ulcer and preparation process for western medicine
InactiveCN105434459ASuppress generationGrowth inhibitionTetracycline active ingredientsDigestive systemDiseaseVitamin C
The invention relates to a formula of a western medicine for treating ulcer and a preparation process for the western medicine. The western medicine is prepared from the following raw materials in parts by weight: 18-22 parts of aluminium hydroxide, 10-15 parts of sucralfate, 6-10 parts of tetracycline, 1-4 parts of vitamin B2, 1-4 parts of vitamin B6, 3-7 parts of vitamin C and 8-12 parts of metronidazole. The western medicine has the advantages of taking effects quickly, being good in treatment effect, having no toxic or side effects and having an excellent effect on gastric ulcer, duodenal ulcer and other diseases.
Owner:NANYANG MEDICAL COLLEGE
Compound dendrobium eye drops for treating xerophthalmia and preparation method thereof
InactiveCN105726983ARich sources of medicineLow costSenses disorderPharmaceutical delivery mechanismTreatment effectCornea epithelium
The invention belongs to the traditional Chinese medicine field, relates to a traditional Chinese medicine prescription for treating xerophthalmia and a preparation method, and more specifically to a compound dendrobium eye drops for treating xerophthalmia and a preparation method thereof. The compound dendrobium eye drops are prepared from the following raw materials: 80-120g of caulis dendrobii, 80-120g of radix trichosanthis, 80-120g of folium isatidis, 50-100g of vitamin B1, and 10-20ml of honey. The eye drops are prepared by a modern advanced medicine pharmaceutical technology and have a reasonable formula which is scientific and advanced. The medicinal herb resource is abundant and the medicine cost is low. The traditional Chinese medicine prescription for treating xerophthalmia has the efficacy of improving eyesight and anti-inflammation, lubricating eye surface, and prompting cornea epithelium growth. A local drug delivery mode is employed, and the medicines directly reach the action position. The compound dendrobium eye drops for treating xerophthalmia provides a safe and effective eye medicinal preparation with convenient use for clinic treatment of the xerophthalmia. The treatment effect is reliable, and the compound dendrobium eye drops for treating xerophthalmia and the preparation method thereof can be popularized.
Owner:QINGDAO HUANGDAO HOSPITAL OF TRADITIONAL CHINESE MEDICINE
Wearable elbow joint ultrasonic physiotherapy instrument
InactiveCN113144444APhysiotherapy reachedTreatment reachedUltrasound therapyPhysical medicine and rehabilitationEngineering
The invention discloses a wearable elbow joint ultrasonic physiotherapy instrument which comprises an ultrasonic treatment assembly, a fixing band and a controller; the ultrasonic treatment assembly comprises an ultrasonic coupling patch and one or more wafers arranged in the ultrasonic coupling patch, and the wafers are used for emitting ultrasonic waves to the skin surface of the wrist joint of the patient when receiving the excitation signals; an ultrasonic treatment assembly fixing device is arranged in the middle of the fixing band, and matched hook-and-loop fasteners are arranged at the two ends of the fixing band; the ultrasonic treatment assembly fixing device is of a hollow cavity structure without a bottom face, a cavity of the ultrasonic treatment assembly fixing device is used for fixing the ultrasonic treatment assembly, and the effective face of the ultrasonic coupling patch is attached to the surface of the elbow joint, and the controller is connected with the wafers of the ultrasonic treatment assembly through cables. According to the wearable elbow joint ultrasonic physiotherapy instrument, the coupling patch is adopted to adhere the elbow joint, soft and moist and firmly fixed through the fixing band, the treatment assembly is based on the ultrasonic coupling patch, a coupling agent does not need to be smeared, and therefore the instrument is more convenient and portable.
Owner:SHANGHAI SIXTH PEOPLES HOSPITAL
Medicine for preventing and/or treating Parkinson's disease and preparation method thereof
InactiveCN108498756ATreatment reachedImprove motor functionNervous disorderPlant ingredientsDiseasePharmaceutical drug
The invention discloses a medicine for preventing and / or treating a Parkinson's disease. Active ingredients of the medicine comprise the following components in parts by weight: 8-15 parts by weight of rhizoma curcumae, 15-25 parts by weight of herba sarcandrae, 15-25 weight of radix lithospermi, 10-20 parts by weight of radix paeoniae rubra, 15-25 parts by weight of rhizoma smilacis glabrae, 15-25 parts by weight of fructus mume, 15-25 parts by weight of radix glycyrrhizae, 15-25 parts by weight of radix angelicae sinensis, 15-25 parts by weight of rhizoma chuanxiong, and 15-25 of radix rehmanniae recens. The medicine for preventing and / or treating the Parkinson's disease, provided by the invention, can improve the motor function of a model rat, and reduce pathological changes of the striatum and the substantia nigra pars compacta, such as reducing the loss of DA neuronal cells, thereby achieving the purpose of treatment of the Parkinson's disease.
Owner:GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE
Externally-applied traditional Chinese medicine composition for treating ankylosing spondylitis and administration mode thereof
InactiveCN104435180ATreatment reachedRelieve painSkeletal disorderConiferophyta medical ingredientsCarthamusLigusticum chuanxiong
The invention discloses an externally-applied traditional Chinese medicine composition for treating ankylosing spondylitis. The composition comprises the following traditional Chinese medicine components by weight: 30-40g of ligusticum wallichii, 5-15g of radix cyathulae, 15-50g of radix saposhnikoviae, 15-20g of notopterygium root, 15-30g of radix angelicae pubescentis, 5-15g of aconite, 10-15g of flowers carthami, 5-10g of myrrh and 15-30g of oriental arborvitae, wherein the traditional Chinese medicine components are the raw powder of the traditional Chinese medicinal materials or traditional Chinese medicine extracts equivalent to the equivalent doses of the traditional Chinese medicinal materials. The invention further discloses an administration mode of the externally-applied traditional Chinese medicine composition for treating ankylosing spondylitis.
Owner:王铁创
Traditional Chinese medicine preparation for treating osteoarthritis and preparation method thereof
InactiveCN106729215ATreat osteoarthritisThe method is simpleSkeletal disorderAlkali/alkaline-earth metal chloride active ingredientsRemove bloodFenugreeks
The invention discloses a traditional Chinese medicine preparation for treating osteoarthritis and a preparation method thereof. Medicinal raw materials for preparing the traditional Chinese medicine preparation include fenugreek, ficus pumila fruit, orobanche coerulescens, eclipta alba, semen cassia, tribulus terrestris, lignum dalbergiae odoriferae, radix notoginseng, wintergreen, chinaroot greenbrier, fluoritum, allium macrostemon, juncus roemerianus, flastem milkvetch seed and couchgrass root. The traditional Chinese medicine preparation for treating osteoarthritis has the beneficial effects that the compatibility of all the medicinal raw materials is appropriate; and the traditional Chinese medicine preparation has the effects of warming the kidney, tonifying yang, invigorating the circulation of blood, removing blood stasis, strengthening sinews and bones, relieving rheumatic pains and removing dampness by dieresis, thereby achieving the purpose of treating osteoarthritis.
Owner:广州中医药大学附属骨伤科医院
Medicine for treating ulcerative colitis and application of fullerene as active component
PendingCN113456673AGood control effectInhibition formationDigestive systemCarbon active ingredientsUlcerative colitisPharmaceutical drug
The invention belongs to the technical field of medicines, and relates to a medicine for treating ulcerative colitis and application of fullerene as an active component of the medicine. The medicine for treating ulcerative colitis contains fullerene and a medicine carrier. Researches show that the fullerene has a good prevention and treatment effect on ulcerative colitis, so that the fullerene can be used as an active component in the medicine for treating ulcerative colitis.
Owner:XIAMEN FUNANO NEW MATERIAL TECH COMPANY
Medicinal composition for treating tachyarrhythmia as well as preparation and preparation method thereof
ActiveCN104940584ATreatment reachedThe effect of treating tachyarrhythmia reachesCardiovascular disorderPlant ingredientsFunctional activitySchisandra chinensis
The invention relates to a medicinal composition and in particular relates to a medicinal composition for treating tachyarrhythmia as well as a preparation and a preparation method thereof. The medicinal composition contains the following components: tree peony bark, red peony root, radix pseudostellariae and dwarf lilyturf tuber; the medicinal composition also contains nutgrass galingale rhizome and combined spicebush root, or Chinese magnoliavine fruit and bitter orange, or also contains nutgrass galingale rhizome, combined spicebush root, coptis root and danshen root, or also contains nutgrass galingale rhizome, combined spicebush root, Chinese magnoliavine fruit and bitter orange. The medicinal composition provided by the invention aims at the pathogenesis of 'fever' and takes 'blood cooling and heat clearing' as a main treatment rule; and by applying the medicinal composition provided by the invention, the effects of invigorating qi and heart, conditioning the functional activity of qi and regulating qi to promote circulation of qi are achieved, so that the aims of treating the tachyarrhythmia is achieved.
Owner:BEIJING CHINESE MEDICINE HOSPITAL AFFILIATED CAPITAL MEDICAL UNIV
Traditional Chinese medicine potion mainly for treating acute and chronic ulcerative colitis and preparation method thereof
InactiveCN106334010ATreatment reachedImprove immunityDispersion deliveryDigestive systemMedicineUlcerative colitis
A traditional Chinese medicine potion mainly for treating acute and chronic ulcerative colitis is composed of radix astragali, Chinese angelica, cassia twig, white peony root, dark plum, scorched hawthorn, cinnamon, banksia rose, hericium erinaceus, alga, prunella vulgaris, licorice and deionized water. The traditional Chinese medicine potion comprises, by mass parts, 20-25 parts of radix astragali, 15-20 parts of Chinese angelica, 15-20 parts of cassia twig, 20-25 parts of white peony root, 10-15 parts of dark plum, 5-10 parts of scorched hawthorn, 3-5 parts of cinnamon, 3-5 parts of banksia rose, 3-5 parts of hericium erinaceus, 5-8 parts of alga, 3-5 parts of prunella vulgaris, 15-20 parts of licorice and 800-1200 parts of deionized water. Radix astragali, Chinese angelica, cassia twig, white peony root, dark plum, scorched hawthorn, cinnamon, banksia rose, hericium erinaceus and licorice are in compatibility to be used for conditioning and treatment of acute and chronic ulcerative colitis, the immunity of the organism can be enhanced if the traditional Chinese medicine potion is used for a long term, yin and yang balance is adjusted, and thus a whole regulation effect is brought into play to achieve the goal of treating ulcerative colitis.
Owner:孙光周
Traditional Chinese medicine composition for inhibiting and removing platelet antibody and curing idiopathic thrombocytopenic purpura
InactiveCN106074837AGood curative effectImprove side effectsDispersion deliveryAluminium/calcium/magnesium active ingredientsDiseaseToxic material
The invention provides a traditional Chinese medicine composition for inhibiting and removing aplatelet antibody and curing idiopathic thrombocytopenic purpura, wherein honeysuckle capable of clearing away heat and toxic materials and good at removing blood poisonis is taken as a monarch drug in a prescription, and is used to remove the platelet antibody in the blood. Radix rehmanniae, cortex moutan, red peony root and ligusticum wallichii are taken as an adjuvant drug, and are used to cool blood, clear heat, improve the internal environment of blood heat of a human body, and prevent and control the internal base for the generation of a blood platelet; lithospermum, madder, nodus nelumbinis rhizomatis charcoal and radix notoginseng powder are used to cool blood, remove blood stasis, stop bleeding and improve the signs and symptoms of bleeding; divaricate saposhnikovia root is used to dispel wind and clear heat, and is compatible with the honeysuckle to avoid relapse of the disease, caused by the reason that wind heat enters the interior. Liquorice is a conductant drug, relaxes tension, detoxifies, and coordinates the drug actions of the prescription. The various medicines in the prescription are combined, the prescription is simple but complete, is in great accuracy and hits the pathogenesis, and the various medicines play the roles of detoxifying, cooling blood, dispersing blood stasis, removing ecchymosis and nourishing spleen and kidney together, so that the bleeding of an ITP patient is reduced, and the various clinical symptoms are further alleviated.
Owner:SHANDONG PROVINCIAL HOSPITAL
Vitiligo treatment traditional Chinese medicine composition
InactiveCN107496810APromote circulationRecovery functionDispersion deliveryUnknown materialsMelanomaSide effect
The invention discloses a vitiligo treatment traditional Chinese medicine composition which comprises ginseng, amomum, cordyceps militaris, yam, purslane, black snake, longan meat, Chinese wolfberry, tuckahoe, houttuynia cordata, peach kernel, black sesame, semen coicis, dandelion, raspberry and spina date seed. The vitiligo treatment traditional Chinese medicine composition is prepared by compounding of a plurality of natural ingredients, is safe and reliable and has no side effect. The vitiligo treatment traditional Chinese medicine composition has the functions of invigorating blood and nourishing qi, clearing away heat and toxic materials, regulating collaterals and regulating qi, clearing the liver and invigorating the kidney, fundamentally improves blood circulation, and accelerates the function recovery of melanoma cells to achieve the purpose of vitiligo treatment. Clinical tests prove that the prepared traditional Chinese medicine composition has an effective treatment rate of 96.4% for patients with progressive vitiligo, and an effective treatment rate of 95.8% for patients with stable vitiligo.
Owner:楚海龙
Silkworm breeding method for preventing and treating silkworm sepsis
The invention discloses a silkworm breeding method for preventing and treating silkworm sepsis, relates to the technical field of silkworm breeding, and solves the problem that in the prior art, the silkworm sepsis causes huge loss to farmers. The method is technically characterized in that before breeding, a silkworm room and silkworm tools are strictly disinfected to avoid infection of residualviruses, silkworm bodies with the silkworm sepsis are isolated and disinfected, and thus, the circumstance that the infection range is expanded due to pus pollution is avoided; disease-resistant drugsare fed for the silkworm bodies at equal intervals to improve the disease resistance of the silkworm bodies, and the method has a good effect on preventing the silkworm sepsis; antibiotics are evenlysprayed to mulberry leaves fed for 4-instar silkworms and 5-instar silkworms, growth of bacteria is prevented and inhibited, meanwhile, the infection probability of the silkworm sepsis is inhibited,and the morbidity of the silkworm sepsis is reduced; and the silkworm bodies with the silkworm sepsis are fed with silkworm sepsis treatment liquid medicine to kill germs in the sick silkworm bodies,and thus, the purpose of treating the sick silkworms is achieved. By means of the simple and easy-to-operate steps and method, the silkworm sepsis is effectively prevented and treated, the morbidity and the fatality rate of the silkworm sepsis are reduced, the economic benefits of silkworm breeding are greatly improved, and popularization is facilitated.
Owner:BIJIE HUIJIANG SILKWORM DEV CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com